PBS Biotech® Named Business of the Year by Pacific Coast Business Times
PBS honored for developing advanced single-use bioreactors for biopharmas to produce vaccines, drugs and biosimilars for global market
“This is a tremendous honor for the PBS Biotech team to be recognized by Pacific Coast Business Times and the business community for our hard work and creativity in developing bioreactors that can accelerate the development of drugs and vaccines worldwide,” said Dr. Lee. “Our focus is to provide our biopharma customers with bioreactors and bioprocess solutions that deliver value and competitive advantage to their business,” he said.
PBS Biotech, which has corporate headquarters here, and includes sales, marketing, engineering, manufacturing and clean room operations, won over more than 70 firms nominated in its category. The company expects to make significant additions to its work force across all sectors over the coming months. The firm is growing rapidly as biopharma firms worldwide adopt single-use bioreactors, which offer lower capital and operating costs, increased manufacturing flexibility and shorten development time to market for drug and vaccine products.
The awards lunch was attended by over 150 local and regional business and government officials including US Rep. Lois Capps, CA-23; Brian Miller representing US Rep. Elton Gallegly, CA-24; Elizabeth Echols, Regional Administrator of the US Small
Business Administration and Bruce Stenslie, EDC-VC president & CEO. Keynote speaker was Linda Weinman, co-founder of lynda.com.
About PBS Biotech
PBS Biotech, Inc. is a U.S. corporation headquartered in Camarillo, California that manufactures fully scalable and easy-to-use single-use bioreactors for global biotechnology organizations. The company has developed innovative, efficient, and scalable bioreactors by combining a patented pneumatic mixing mechanism with an advanced, proprietary control system. This novel bioreactor solution offers improved operational efficiency and flexibility with reduced costs and ultimately shorter time to market for biotechnology customers. PBS Biotech is poised for rapid growth by supporting industry demand for single-use technologies.
Contact: Rick Sullivan, VP Sales & Marketing